SALES FORECAST: The Swiss pharma giant's third-quarter sales are forecast at 14.89 billion Swiss francs ($17.22 billion), according to a consensus of 11 analysts' estimates compiled by Visible Alpha.
--FEE MOMENTUM: For banks in both the U.K. and Asia, non-interest income should prove resilient as banks' wealth and insurance operations have shown good trends in the quarter, particularly in Hong ...
Shares of automotive supplier Forvia (EPA: FRVIA) jumped on Monday after the company reported slightly better-than-expected sales for the third quarter, with anal ...